What does CUSIP 413197104 represent in this 13F holders report?

CUSIP 413197104 is the security identifier for HRMY - Harmony Biosciences Holdings, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in Q3 2020?

44 institutional investors reported HRMY - Harmony Biosciences Holdings, Inc. - Common Stock for Q3 2020. Use the holders table for investor-level position and value details.

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

CUSIP: 413197104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock
Shares outstanding: 57,644,670
Total 13F shares: 28,549,056
Share change: +28,549,056
Total reported value: $940,508,000
Price per share: $33.90
Number of holders: 44
Value change: +$940,508,000
Number of buys: 44

Quarterly Holders Quick Answers

What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020

Recent filing periods for CUSIP 413197104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2020

As of 30 Sep 2020, Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,549,056 shares. The largest 10 holders included FMR LLC, Vivo Capital, LLC, Novo Holdings A/S, venBio Partners LLC, Newlight Partners LP, JANUS HENDERSON GROUP PLC, Aisling Capital Management LP, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, and BAKER BROS. ADVISORS LP. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q4 2025 Across Filers

Q4 2025 holders

321

Q3 2020 holders

Holder diff

-277

Investor	Q4 2025 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.